| Pretraživanje | Osvježi |
|
RheoSense
@RheoSense
|
8 h |
|
What's the cost of selecting the right #CRO? Make sure you are aware of all of the tests possible and contact us if you need help getting recommended CROs and #CDMOs!
blog.rheosense.com/cros-cdmo
|
||
|
|
||
|
Dan Stanton
@Dan5tanton
|
30. sij |
|
Lack of good #CDMOs a factor for @KrystalBiotech in investing $70-90m into internal PA gene therapy plant buff.ly/2Obgc1e pic.twitter.com/wqhhN650eL
|
||
|
||
|
CCRM
@CCRM_ca
|
20. lip |
|
CCRM is excited to launch a brand new initiative. We are answering your Qs on a variety of topics related to #CARTs #CGTs #GMP working with #CDMOs...and if you don't know these acronyms, you should definitely check it out! ccrm.ca/cdmo_education… #Biotechnology #STEM pic.twitter.com/aad829JLKi
|
||
|
|
||
|
3PBiopharmaceuticals
@3PBio
|
19. ruj |
|
We are so very proud to share the news about our #FDA approval!! This achievement positions us at the level of the most distinguished #CDMOs in the world and represents a very important breakthrough in the history of 3P. 3pbio.com/2019/09/18/3p-… pic.twitter.com/RfExhOFPxR
|
||
|
||
|
53Biologics
@53Biologics
|
13. pro |
|
🌲🎁#countdown #Christmas #53Biologics
Our #mission is to provide #services to different companies, from start-ups to large companies, as well as to other #CDMOs, to help their products to reach the market
#pharma #biotecnology #biotech #microbiology pic.twitter.com/IvEvlubW46
|
||
|
||
|
CM Life Science
@cm_lifescience
|
19. kol |
|
"Fear of innovation in the East will drive innovation in the West."
Do Western CMOs need to 'up their game' to combat an increasingly Eastern-facing market?
Read our latest article
👉bit.ly/2Z0t8JQ
#CMOs #CDMOs #pharma #pharmaceuticals #innovation #NCEs pic.twitter.com/0hpijXCKK5
|
||
|
|
||
|
Cornell Stamoran
@stamoran
|
15. lis |
|
Pharma #CDMOS: long time veteran observer and good friend Jim Miller reflects on 20+ years’ learnings at #PBOACON19 @PBOAssoc pic.twitter.com/AM6hVZ8XHL
|
||
|
||
|
Sterling Pharma
@sterling_pharma
|
20. ožu |
|
It's important for #CDMOs to be fully transparent when it comes to audits to ensure the correct quality is achieved. Read more: bit.ly/2Fi7au7 via @OutsourcedPharm
|
||
|
|
||
|
Generics bulletin
@Genericbulletin
|
3. velj |
|
Discover insider information from a recent roundtable discussion about the use of #CDMOs and what companies are looking for from them and much more. Download your copy here bit.ly/2uGKQZq pic.twitter.com/UR98IGwsCr
|
||
|
||
|
Biotech Essentials
@biotech_innov
|
31. sij |
|
‘Lack of good CDMOs’ factor for Krystal’s $90m gene therapy plant buff.ly/2u9eTcv #biotech #startups #CDMOs via @Xconomy
|
||
|
|
||
|
Onyx Scientific
@onyxscientific1
|
27. stu |
|
Although pharmaceutical companies choose to #outsource for different reasons, many businesses work with CROs, CMOs and #CDMOs because it can reduce the overall cost and risk of their project. Explore the other factors driving a surge in outsourcing here: bit.ly/32gaC1Z pic.twitter.com/U3fTaoXABL
|
||
|
||
|
Johnson Matthey
@Johnson_Matthey
|
19. stu |
|
"Outsourcing is a very effective way for pharma companies to tap into additional formulation expertise.”
Our Global VP Innovator Products and Solutions, Nick Shackley, examines the growing partnership between #CDMOs and #Pharma in @medicine_maker: bit.ly/2E6DcK1 pic.twitter.com/KSObEAxEMA
|
||
|
||
|
Parc Científic de Barcelona
@PCB_UB
|
4. stu |
|
On 12 November we organise with @biocat_en the workshop 'Technologies for improving bioavalilability of poorly water-soluble #drugs' by Dr A. Loxley, consultant of #ParticleSciences (@LZLifeSciHealth), one of the world's leading #CDMOs ▶️bit.ly/31JnoFZ
Don't miss it! 👍 pic.twitter.com/WPl44nAwmQ
|
||
|
||
|
Patheon
@Patheon
|
29. lis |
|
.@Cenmag interviewed Michel Lagarde, Executive VP of Thermo Fisher Scientific, about the challenges #CDMOs are facing as the pharma and #biotech markets rapidly grow. bit.ly/2Mq8Qqh
|
||
|
|
||
|
UnseenValue
@unseenvalue
|
23. lis |
|
Ready to use next-gen technology platforms and shift in portfolios from large volumes but simple, to lower volumes but complex or orphan molecules or even the lack of approved capacity for complex/sterile drugs are some reasons the #CDMOs have started to feel real +ve traction.
|
||
|
|
||
|
CHEManager International
@CHEManager_EU
|
29. ruj |
|
The #pharmaceuticalindustry continues to grow and is estimated at $1.5 trillion by 2021. An important driver is the trend to #outsource development and manufacturing to #CDMOs. We have asked executives working in this market to share their experiences. bit.ly/2Na7eTf pic.twitter.com/PgJ6CQFqg3
|
||
|
||
|
Intalere
@Intalere
|
26. ruj |
|
Supply chain digitization creates new revenue opportunities in the vaccine market via @HPN_Online ow.ly/PFu130pBZyb #SupplyChain #HealthcareSupplyChain #Vaccines #PublicHealth #CDMOs
|
||
|
|
||
|
Simon-Kucher
@simonkucher
|
20. ruj |
|
In order to capitalize on the trend to outsource product development and manufacturing, #CDMOs need to continuously optimize their #commercial strategy by establishing and enforcing a value-based pricing concept. Our experts commented for @CHEManager_EU. bit.ly/2QfKNhC pic.twitter.com/Fb993Psw9r
|
||
|
||
|
Life Science Integrates
@LSIntegrates
|
12. ruj |
|
In this panel at #PharmaIntegrates, we examine the future of #largemolecules vs #smallmolecules and the implications for #CDMOs. Panellists represent @AlcamiNow, @LillyPad, @XenoGesis, @pfizer and @AstraZeneca. Find out more: lifescienceintegrates.com/pharma-integra… #pharma pic.twitter.com/m2cfNCEuDE
|
||
|
||
|
Johnson Matthey
@Johnson_Matthey
|
5. kol |
|
"A good CDMO is not just about doing what they are told – the best are also consultants and collaborators.”
Our Global VP Innovator Products and Solutions, Nick Shackley, shares his insights on partnerships between #CDMOs and #Pharma in @medicine_maker: bit.ly/2E6DcK1 pic.twitter.com/fV9WDFKKLa
|
||
|
||